Literature DB >> 2177615

DNA ploidy in intraductal breast carcinomas.

T A Aasmundstad1, O A Haugen.   

Abstract

Cellular DNA-ploidy in 74 clinically detected intraductal breast carcinomas (IDCs) was analysed by flow cytometry. The histograms were classified as either diploid or aneuploid, and the DNA ploidy pattern compared with that of invasive breast carcinomas and normal breast tissue. All normal breast tissues were diploid while 28 (38%) of the IDCs were aneuploid, the DNA indices ranging from 1.32 to 2.00. The frequency of aneuploidy in invasive ductal carcinomas (73%) was significantly higher (P = 0.003), DNA index ranging from 1.34 to 2.92, compared with that in IDCs. Retrospectively, 14.5% of the patients had invasive breast cancer 16-166 months after the diagnosis of IDC. Neither DNA ploidy nor histopathological classification alone predicted clinical outcome, but patients with DNA diploid non-comedo IDC had a more favourable course.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177615     DOI: 10.1016/0277-5379(90)90619-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

Review 1.  Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.

Authors:  P S Steeg; S E Clare; J A Lawrence; Q Zhou
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

2.  Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.

Authors:  Malathy P V Shekhar; Larry Tait; Robert J Pauley; Gen Sheng Wu; Steven J Santner; Pratima Nangia-Makker; Varun Shekhar; Hind Nassar; Daniel W Visscher; Gloria H Heppner; Fred R Miller
Journal:  Cancer Biol Ther       Date:  2008-11-12       Impact factor: 4.742

3.  Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.

Authors:  S A Brooks; A J Leathem; R S Camplejohn; W Gregory
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 4.  Immunohistochemical studies of early breast cancer evolution.

Authors:  D C Allred; P O'Connell; S A Fuqua; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.

Authors:  C J Fabian; C Zalles; S Kamel; B F Kimler; R McKittrick; A S Tranin; S Zeiger; W P Moore; R S Hassanein; C Simon
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 6.  Current management of ductal carcinoma in situ.

Authors:  A Barth; R J Brenner; A E Giuliano
Journal:  West J Med       Date:  1995-10

7.  Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

Authors:  S T Brower; S Ahmed; P I Tartter; I Bleiweiss; J B Amberson
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

8.  Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup.

Authors:  Malathy P V Shekhar; Ikuko Kato; Pratima Nangia-Makker; Larry Tait
Journal:  Oncotarget       Date:  2013-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.